Salivary and Sinonasal Tumors: Multi-Disciplinary Individualization of Patient Care

Sinonasal and salivary malignancies are less common head and neck tumors but are still frequently seen by radiation oncologists and pose complex clinical decision making challenges due to the proximity to the facial nerve, optic structures, brain, and oral cavity. Treatments can radically affect patient appearance, psychosocial well-being, vision, speech/swallow function, and breathing. This activity includes clinical scenarios that highlight challenges in management approaches. Panelists provide the radiation oncology, medical oncology, and head/neck surgical perspectives on management and optimizing patient function. The activity will (1) review the integration of multi-disciplinary care including radiation, surgery, and systemic therapy to optimize oncologic outcomes and functional/cosmetic outcomes; (2) review advances in molecular and genetic characterization of the most common salivary/sinonasal tumors and how this influences systemic therapy and clinical trials; (3) definitive and postoperative radiation techniques; and (4) reconstruction options for orbital, nasal, and palatal function.

Topics:

  1. Introductions and Case 1 - Salivary Malignancy
    Danielle Margalit, MD, MPH, Karen Choi, MD and Glenn J. Hanna, MD
  2. Case 2 - Sinonasal Tumors
    Danielle Margalit, MD, MPH, Karen Choi, MD and Glenn J. Hanna, MD
  3. Q and A

This activity is available from January 23, 2024, through 11:59 p.m. Eastern time on January 22, 2026. 

This activity was originally recorded at the 2023 ASTRO Annual Meeting.

Target Audience

The activity is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, nurses, radiation dosimetrists, residents, and prosthodontist specialists.  

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Determine optimal sequence of surgery, radiation, and systemic therapy in management of early-stage and locally advanced salivary and sinonasal malignancies to optimize oncologic and functional outcomes.
  • Describe approaches to integration of systemic therapy.
  • Explain considerations for reconstruction after common surgeries for salivary or sinonasal tumors including maxillectomy and facial nerve sacrifice. 
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.
Course opens: 
01/23/2024
Course expires: 
01/22/2026
Cost:
$0.00
Rating: 
0
  • Danielle N. Margalit, MD, MPH, is employed by Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School.   
  • Karen Y. Choi, MD, is employed by Penn State Health. Dr. Choi receives consultant fees from Cardinal Health.
  • Glenn J. Hanna, MD, is employed by the Center for Head & Neck Oncology, Center for Salivary and Rare Head and Neck Cancers, Dana-Farber Cancer Institute, Harvard Medical School. Dr. Hanna receives research funding from ACCRF, Actuate, Elevar, Gateway for Cancer Research, Genentech, ImmunityBio, Kura Oncology, and V Foundation. Dr. Hanna serves in an advisory/consultant role for Boxer Capital, BMS, Elevar, General Catalyst, Kura, Massachusetts Medical Society, Prelude, Remix and Replimune. 

  

The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.

Price

Cost:
$0.00
Please login or register to take this course.

Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the member rate.

Nonmember: $149
Member: $99
Member-in-training: $49
Student/Grad Student/PGY: $49
Postdoctoral Fellow: $49
 

Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.

Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.

The course and its materials will only be available on the ASTRO website until January 22, 2026, regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.